10-Q Filing

Oruka Therapeutics, Inc. CIK: 907654 Q3 2013

Filing Information

Form Type	10-Q
Accession Number	`0001564590-13-001316`
Period End Date	20130930
Filing Date	20131113
Fiscal Year	2013
Fiscal Period	Q3
XBRL Instance	abio-20130930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 57 Income Statement 72 Cash Flow Statement 98 Stockholders Equity 76

Balance Sheet 57 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.08M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.94M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.92M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$18.63M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$379.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$125.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$19.01M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.04M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$27.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$23.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$100.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$144.00K	USD	Point-in-time
Total assets	`Assets`	$3.21M	USD	Point-in-time
Total assets	`Assets`	$19.14M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$65.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$447.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$103.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$75.00K	USD	Point-in-time
Accrued expenses and other liabilities	`OtherLiabilitiesCurrent`	$247.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	2.66M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	13.20M	shares	Point-in-time
Accrued expenses and other liabilities	`OtherLiabilitiesCurrent`	$121.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	13.20M	shares	Point-in-time
Deferred rent, current portion	`DeferredRentCreditCurrent`	$16.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	2.66M	shares	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$769.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$305.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$305.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$769.00K	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Series A convertible preferred stock, $0.001 par value; 135,000 shares authorized; 24,902 shares issued and outstanding at September 30, 2013; no shares authorized, issued and outstanding at December 31, 2012	`PreferredStockValue`	-	USD	Point-in-time
Series A convertible preferred stock, $0.001 par value; 135,000 shares authorized; 24,902 shares issued and outstanding at September 30, 2013; no shares authorized, issued and outstanding at December 31, 2012	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 100 million shares authorized; 13,195,362 shares issued and outstanding at September 30, 2013; 2,660,315 shares issued and outstanding at December 31, 2012.	`CommonStockValue`	$3.00K	USD	Point-in-time
Common stock, $0.001 par value; 100 million shares authorized; 13,195,362 shares issued and outstanding at September 30, 2013; 2,660,315 shares issued and outstanding at December 31, 2012.	`CommonStockValue`	$13.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$90.34M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$70.90M	USD	Point-in-time
Deficit accumulated during the development stage	`RetainedEarningsAccumulatedDeficit`	$-67.99M	USD	Point-in-time
Deficit accumulated during the development stage	`RetainedEarningsAccumulatedDeficit`	$-71.99M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$2.91M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$-678.00K	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$7.41M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$18.37M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$5.73M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$-19.69M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$-619.00K	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$-115.00K	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$6.77M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	-	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$-38.18M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$-5.74M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$19.14M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$3.21M	USD	Point-in-time

Income Statement 72 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$1.14M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$901.00K	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$43.82M	USD	47 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$714.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$156.00K	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$772.00K	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$2.58M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$1.01M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$45.44M	USD	47 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$2.85M	USD	3 Qtrs
Merger transaction costs	`BusinessCombinationAcquisitionRelatedCosts`	$5.47M	USD	47 Qtrs
Restructuring expense, net	`RestructuringCharges`	$2.41M	USD	47 Qtrs
Loss on impairment of in-process research and development	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$6.00M	USD	47 Qtrs
Total costs and expenses	`OperatingExpenses`	$3.99M	USD	3 Qtrs
Total costs and expenses	`OperatingExpenses`	$1.73M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$928.00K	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$3.48M	USD	3 Qtrs
Total costs and expenses	`OperatingExpenses`	$103.14M	USD	47 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-1.73M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-928.00K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-3.48M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-3.99M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-103.14M	USD	47 Qtrs
Gain on assignment of patent rights	`GainLossOnAssignmentOfPatentRights`	$2.00M	USD	47 Qtrs
Gain on bargain purchase	`BusinessCombinationBargainPurchaseGainRecognizedAmount`	$25.30M	USD	Point-in-time
Gain on bargain purchase	`BusinessCombinationBargainPurchaseGainRecognizedAmount`	$25.28M	USD	47 Qtrs
Interest and other income	`InterestAndOtherIncome`	$2.03M	USD	47 Qtrs
Interest and other income	`InterestAndOtherIncome`	$3.00K	USD	3 Qtrs
Interest and other income	`InterestAndOtherIncome`	$2.00K	USD	1 Quarter
Interest and other income	`InterestAndOtherIncome`	$3.00K	USD	3 Qtrs
Interest and other income	`InterestAndOtherIncome`	$2.00K	USD	1 Quarter
Interest and other expense	`InterestExpenseDebt`	$1.00K	USD	1 Quarter
Interest and other expense	`InterestExpenseDebt`	$445.00K	USD	47 Qtrs
Interest and other expense	`InterestExpenseDebt`	$3.00K	USD	3 Qtrs
Interest and other expense	`InterestExpenseDebt`	$3.00K	USD	3 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-3.99M	USD	3 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-74.27M	USD	47 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-1.72M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-927.00K	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-3.48M	USD	3 Qtrs
Benefit from income taxes	`IncomeTaxExpenseBenefit`	$-2.28M	USD	47 Qtrs
Net loss and comprehensive loss	`NetIncomeLoss`	$-71.99M	USD	47 Qtrs
Net loss and comprehensive loss	`NetIncomeLoss`	$-9.14M	USD	Annual
Net loss and comprehensive loss	`NetIncomeLoss`	$-5.24M	USD	Annual
Net loss and comprehensive loss	`NetIncomeLoss`	$-3.99M	USD	3 Qtrs
Net loss and comprehensive loss	`NetIncomeLoss`	$-927.00K	USD	1 Quarter
Net loss and comprehensive loss	`NetIncomeLoss`	$-1.72M	USD	1 Quarter
Net loss and comprehensive loss	`NetIncomeLoss`	$-8.42M	USD	Annual
Net loss and comprehensive loss	`NetIncomeLoss`	$-511.00K	USD	Annual
Net loss and comprehensive loss	`NetIncomeLoss`	$-5.36M	USD	Annual
Net loss and comprehensive loss	`NetIncomeLoss`	$-1.46M	USD	Annual
Net loss and comprehensive loss	`NetIncomeLoss`	$-19.43M	USD	Annual
Net loss and comprehensive loss	`NetIncomeLoss`	$-116.00K	USD	8 Qtrs
Net loss and comprehensive loss	`NetIncomeLoss`	$-13.99M	USD	Annual
Net loss and comprehensive loss	`NetIncomeLoss`	$-3.48M	USD	3 Qtrs
Net loss and comprehensive loss	`NetIncomeLoss`	$-4.32M	USD	Annual
Less: Accretion of redeemable convertible preferred stock	`PreferredStockAccretionOfRedemptionDiscount`	$245.00K	USD	47 Qtrs
Less: Deemed preferred stock dividend	`PreferredStockDividendsAndOtherAdjustments`	$2.03M	USD	3 Qtrs
Less: Deemed preferred stock dividend	`PreferredStockDividendsAndOtherAdjustments`	$2.81M	USD	47 Qtrs
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-927.00K	USD	1 Quarter
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-6.02M	USD	3 Qtrs
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.72M	USD	1 Quarter
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.48M	USD	3 Qtrs
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-75.04M	USD	47 Qtrs
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.96	USD	3 Qtrs
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.16	USD	1 Quarter
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-1.65	USD	3 Qtrs
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.41	USD	1 Quarter
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	6.30M	shares	3 Qtrs
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	2.11M	shares	3 Qtrs
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	2.28M	shares	1 Quarter
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	10.83M	shares	1 Quarter

Cash Flow Statement 98 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-71.99M	USD	47 Qtrs
Net loss	`NetIncomeLoss`	$-9.14M	USD	Annual
Net loss	`NetIncomeLoss`	$-5.24M	USD	Annual
Net loss	`NetIncomeLoss`	$-3.99M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-927.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.72M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.42M	USD	Annual
Net loss	`NetIncomeLoss`	$-511.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-5.36M	USD	Annual
Net loss	`NetIncomeLoss`	$-1.46M	USD	Annual
Net loss	`NetIncomeLoss`	$-19.43M	USD	Annual
Net loss	`NetIncomeLoss`	$-116.00K	USD	8 Qtrs
Net loss	`NetIncomeLoss`	$-13.99M	USD	Annual
Net loss	`NetIncomeLoss`	$-3.48M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-4.32M	USD	Annual
Gain on patent rights assignment	`GainLossOnAssignmentOfPatentRights`	$2.00M	USD	47 Qtrs
Gain on bargain purchase	`BusinessCombinationBargainPurchaseGainRecognizedAmount`	$25.30M	USD	Point-in-time
Gain on bargain purchase	`BusinessCombinationBargainPurchaseGainRecognizedAmount`	$25.28M	USD	47 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$24.00K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$34.00K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$1.80M	USD	47 Qtrs
Non-cash interest expense	`PaidInKindInterest`	$211.00K	USD	47 Qtrs
Share-based compensation	`ShareBasedCompensation`	$125.00K	USD	3 Qtrs
Share-based compensation	`ShareBasedCompensation`	$243.00K	USD	3 Qtrs
Share-based compensation	`ShareBasedCompensation`	$2.71M	USD	47 Qtrs
Issuance of warrants for lease termination	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$377.00K	USD	47 Qtrs
Accretion of liabilities	`AccretionExpense`	$152.00K	USD	47 Qtrs
Impairment of property and equipment	`ImpairmentOfLongLivedAssetsHeldForUse`	$125.00K	USD	47 Qtrs
Loss on impairment of in-process research and development	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$6.00M	USD	47 Qtrs
Write-off of deferred tax liability	`WriteOffOfDeferredTaxLiability`	$2.28M	USD	47 Qtrs
Gain on marketable securities available for sale	`MarketableSecuritiesGainLoss`	$263.00K	USD	47 Qtrs
(Gain) loss from disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-83.00K	USD	47 Qtrs
Other, net	`OtherNoncashIncomeExpense`	$-267.00K	USD	47 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-2.74M	USD	47 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-219.00K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$80.00K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-44.00K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-7.37M	USD	47 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-60.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$382.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-141.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-1.74M	USD	47 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-19.12M	USD	47 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-318.00K	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$98.00K	USD	3 Qtrs
Deferred rent	`IncreaseDecreaseInDeferredCharges`	$25.00K	USD	3 Qtrs
Deferred rent	`IncreaseDecreaseInDeferredCharges`	$16.00K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.42M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.41M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-100.84M	USD	47 Qtrs
Cash received from Merger	`CashAcquiredFromAcquisition`	$30.39M	USD	47 Qtrs
Payment of deferred transaction costs	`OtherPaymentsToAcquireBusinesses`	$1.19M	USD	47 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.00K	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$28.00K	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.91M	USD	47 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$15.37M	USD	47 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$358.00K	USD	47 Qtrs
Proceeds from patent rights assignment	`ProceedsFromSaleOfIntangibleAssets`	$2.00M	USD	47 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-28.00K	USD	3 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$45.03M	USD	47 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.00K	USD	3 Qtrs
Proceeds from issuance of convertible notes payable and related warrants for common stock	`ProceedsFromIssuanceOrSaleOfEquity`	$10.84M	USD	47 Qtrs
Proceeds from issuance of bank note payable	`ProceedsFromNotesPayable`	$4.00M	USD	47 Qtrs
Proceeds from stock subject to repurchase	`ProceedsFromIssuanceOfRestrictedStock`	$38.00K	USD	47 Qtrs
Proceeds from the issuance of preferred stock	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	$20.00M	USD	3 Qtrs
Proceeds from the issuance of preferred stock	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	$52.32M	USD	47 Qtrs
Payment of offering costs	`PaymentsOfStockIssuanceCosts`	$-20.00K	USD	3 Qtrs
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.74M	USD	3 Qtrs
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$953.00K	USD	3 Qtrs
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$15.85M	USD	47 Qtrs
Repayment of principal on bank note payable	`RepaymentsOfNotesPayable`	$4.00M	USD	47 Qtrs
Repayment of principal on convertible notes payables	`RepaymentsOfConvertibleDebt`	$105.00K	USD	47 Qtrs
Repayment of principal on vendor finance agreement	`RepaymentOfPrincipalOnVendorFinanceAgreement`	$454.00K	USD	47 Qtrs
Repayment of principal on vendor finance agreement	`RepaymentOfPrincipalOnVendorFinanceAgreement`	$174.00K	USD	3 Qtrs
Repayment of principal on vendor finance agreement	`RepaymentOfPrincipalOnVendorFinanceAgreement`	$134.00K	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$19.16M	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$547.00K	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$74.44M	USD	47 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-2.86M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$15.71M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$18.63M	USD	47 Qtrs
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$3.08M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$5.94M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.92M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$18.63M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$3.08M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$5.94M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.92M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$18.63M	USD	Point-in-time
Interest paid	`InterestPaid`	$118.00K	USD	47 Qtrs
Interest paid	`InterestPaid`	$3.00K	USD	3 Qtrs
Interest paid	`InterestPaid`	$3.00K	USD	3 Qtrs
Accrued interest on notes payable converted to equity	`AccruedInterestOnNotesPayableConvertedToEquity`	$163.00K	USD	47 Qtrs
Warrant issued in connection with credit facility	`WarrantIssuedInConnectionWithCreditFacility`	$111.00K	USD	47 Qtrs
Accrued deferred transaction costs	`AccruedDeferredTransactionCosts`	$482.00K	USD	47 Qtrs
Vendor finance agreement	`VendorFinanceAgreement`	-	USD	3 Qtrs
Vendor finance agreement	`VendorFinanceAgreement`	-	USD	3 Qtrs
Vendor finance agreement	`VendorFinanceAgreement`	-	USD	47 Qtrs

Stockholders Equity 76 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, value	`StockholdersEquity`	$2.91M	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$-678.00K	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$7.41M	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$18.37M	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$5.73M	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$-19.69M	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$-619.00K	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$-115.00K	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$6.77M	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	-	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$-38.18M	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$-5.74M	USD	Point-in-time
Beginning Balance, shares	`SharesOutstanding`	-	shares	Point-in-time
Issuance of stock for cash, net of offering costs, value	`StockIssuedDuringPeriodValueNewIssues`	$1.00K	USD	Annual
Issuance of stock for cash, net of offering costs, value	`StockIssuedDuringPeriodValueNewIssues`	$7.18M	USD	Annual
Issuance of stock for cash, net of offering costs, value	`StockIssuedDuringPeriodValueNewIssues`	$1.42M	USD	3 Qtrs
Issuance of stock for cash, net of offering costs, value	`StockIssuedDuringPeriodValueNewIssues`	$7.00K	USD	Annual
Issuance of stock for cash, net of offering costs, value	`StockIssuedDuringPeriodValueNewIssues`	$1.00K	USD	8 Qtrs
Net loss	`NetIncomeLoss`	$-71.99M	USD	47 Qtrs
Net loss	`NetIncomeLoss`	$-9.14M	USD	Annual
Net loss	`NetIncomeLoss`	$-5.24M	USD	Annual
Net loss	`NetIncomeLoss`	$-3.99M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-927.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.72M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.42M	USD	Annual
Net loss	`NetIncomeLoss`	$-511.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-5.36M	USD	Annual
Net loss	`NetIncomeLoss`	$-1.46M	USD	Annual
Net loss	`NetIncomeLoss`	$-19.43M	USD	Annual
Net loss	`NetIncomeLoss`	$-116.00K	USD	8 Qtrs
Net loss	`NetIncomeLoss`	$-13.99M	USD	Annual
Net loss	`NetIncomeLoss`	$-3.48M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-4.32M	USD	Annual
Ending Balance, value	`StockholdersEquity`	$2.91M	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$-678.00K	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$7.41M	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$18.37M	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$5.73M	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$-19.69M	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$-619.00K	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$-115.00K	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$6.77M	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	-	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$-38.18M	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$-5.74M	USD	Point-in-time
Ending Balance, shares	`SharesOutstanding`	-	shares	Point-in-time
Issuance of common stock upon exercise of stock options, for cash, value	`StockIssuedDuringPeriodValueStockOptionsExercised`	$139.00K	USD	Annual
Issuance of common stock upon exercise of stock options, for cash, value	`StockIssuedDuringPeriodValueStockOptionsExercised`	$114.00K	USD	Annual
Issuance of common stock upon exercise of stock options, for cash, value	`StockIssuedDuringPeriodValueStockOptionsExercised`	$16.00K	USD	Annual
Issuance of common stock upon exercise of stock options, for cash, value	`StockIssuedDuringPeriodValueStockOptionsExercised`	-	USD	Annual
Issuance of common stock upon exercise of stock options, for cash, value	`StockIssuedDuringPeriodValueStockOptionsExercised`	$54.00K	USD	Annual
Issuance of common stock upon exercise of stock options, for cash, value	`StockIssuedDuringPeriodValueStockOptionsExercised`	$3.00K	USD	Annual
Issuance of common stock upon exercise of stock options, for cash, shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	-	shares	Annual
Issuance of common stock upon exercise of stock options, for cash, shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	-	shares	3 Qtrs
Offering costs	`AccretionOfOfferingCostEffectOnEquity`	$-17.00K	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$125.00K	USD	3 Qtrs
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$845.00K	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$458.00K	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$39.00K	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$308.00K	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$50.00K	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$545.00K	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$306.00K	USD	Annual
Estimated fair value of warrants issued in connection with convertible notes payable	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$399.00K	USD	Annual
Deemed preferred stock dividend for additional common shares issuable under anti-dilution provision	`DividendsPreferredStockStock`	$-781.00K	USD	Annual
Restricted stock release from restriction	`AdjustmentToAdditionalPaidInCapitalRestrictedStockReleaseFromRestriction`	$75.00K	USD	Annual
Conversion of warrants for preferred stock	`AdjustmentToAdditionalPaidInCapitalConversionOfWarrantsForPreferredStock`	$36.00K	USD	Annual
Merger with Nuvelo, Inc., value	`StockIssuedDuringPeriodValueAcquisitions`	$11.91M	USD	Annual
Issuance of common stock under employee stock purchase plan and upon vesting of restricted stock units, value	`StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan`	$2.00K	USD	Annual
Estimated fair value of warrants issued in connection with lease termination	`AdjustmentToAdditionalPaidInCapitalEstimatedFairValueOfWarrantsIssued`	$377.00K	USD	Annual
Issuance of common stock upon exercise of stock warrants, for cash, value	`StockIssuedDuringPeriodValueWarrantsExercised`	$12.00K	USD	3 Qtrs
Issuance of Series A convertible preferred stock, net of offering costs, Value	`PreferredStockIssuedDuringPeriodValueNewIssues`	$17.92M	USD	3 Qtrs
Deemed preferred stock dividend for beneficial conversion feature	`DeemedDividendBeneficialConversionPreferredStock`	$2.03M	USD	3 Qtrs
Less: Deemed preferred stock dividend	`PreferredStockDividendsAndOtherAdjustments`	$2.03M	USD	3 Qtrs
Less: Deemed preferred stock dividend	`PreferredStockDividendsAndOtherAdjustments`	$2.81M	USD	47 Qtrs
Costs of issuance of common stock and conversion of preferred stock to common stock	`PaymentsOfStockIssuanceCosts`	$-20.00K	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.